Summary

Global Biomarkers Market is valued approximately at USD 51.81 Million in 2020 and is anticipated to grow with a healthy growth rate of more than 14% over the forecast period 2021-2027.The global Biomarkers market is being driven by increase in funding for biomarkers and rising prevalence of chronic diseases. Furthermore, new technological advancements and new launches, will provide new opportunities for the global Biomarkers industry. For instance, according to the World Population Prospects report of 2019, one in every six people across world will be over 65 years of age by year 2050, which may rise the incidences of chronic diseases. Also, in march 2021, a non-diagnostic screening device based on novel biomarker was approved by US FDA called as Tiger Tech Covid plus monitor . However, lack of reimbursement policies for biomarkers treatment, may impede market growth over the forecast period of 2021-2027.

Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global biomarkers. Rise in consumer awareness, proactive government action and technological advancement in healthcare infrastructure. makes North America the leading region across the world in terms of market share. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to presence of key market players and establishment of research institutes .
Major market player included in this report are:

F. Hoffmann-la roche ltd
Abbott laboratories
Epigenomics ag
General electric
Johnson & Johnson services, inc.
Thermo fisher scientific, Inc.
Bio-rad laboratories, inc.
Siemens healthineers ag
Qiagen

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Safety
Efficacy
Validation
By Disease:
Cancer
Cardiovascular Diseases
Neurological Diseases
Immunological Diseases
Others
By Application:
Diagnostics
Drug Discovery and Development
Personalized Medicine
Others


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Biomarkers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Biomarkers Market , by Region, 2019-2027 (USD Billion)
1.2.2. Biomarkers Market , by Type, 2019-2027 (USD Billion)
1.2.3. Biomarkers Market , by Disease , 2019-2027 (USD Billion)
1.2.4. Biomarkers Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biomarkers Market Dynamics
3.1. Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing funding for biomarkers
3.1.1.2. Increasing prevalence of chronic diseases
3.1.2. Market Restraint
3.1.2.1. Lack of reimbursement policies for biomarkers treatment
3.1.3. Market Opportunities
3.1.3.1. Technological Advancements
Chapter 4. Global Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Biomarkers Market , by Type
5.1. Market Snapshot
5.2. Global Biomarkers Market by Type, Performance - Potential Analysis
5.3. Global Biomarkers Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Biomarkers Market , Sub Segment Analysis
5.4.1. Safety
5.4.2. Efficacy
5.4.3. Validation
Chapter 6. Global Biomarkers Market , by Disease
a. Market Snapshot
6.1. Global Biomarkers Market by Disease, Performance - Potential Analysis
6.2. Global Biomarkers Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
6.3. Biomarkers Market , Sub Segment Analysis
6.3.1. Cancer
6.3.2. Cardiovascular Diseases
6.3.3. Neurological Diseases
6.3.4. Immunological Diseases
6.3.5. Others
Chapter 7. Global Biomarkers Market , by Application
b. Market Snapshot
7.1. Global Biomarkers Market by Application, Performance - Potential Analysis
7.2. Global Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Biomarkers Market , Sub Segment Analysis
7.3.1. Diagnostics
7.3.2. Drug Discovery and Development
7.3.3. Personalized Medicine
7.3.4. Others
Chapter 8. Global Biomarkers Market , Regional Analysis
8.1. Biomarkers Market , Regional Market Snapshot
8.2. North America Biomarkers Market
8.2.1. U.S. Biomarkers Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Disease breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Biomarkers Market
8.3. Europe Biomarkers Market Snapshot
8.3.1. U.K. Biomarkers Market
8.3.2. Germany Biomarkers Market
8.3.3. France Biomarkers Market
8.3.4. Spain Biomarkers Market
8.3.5. Italy Biomarkers Market
8.3.6. Rest of Europe Biomarkers Market
8.4. Asia-Pacific Biomarkers Market Snapshot
8.4.1. China Biomarkers Market
8.4.2. India Biomarkers Market
8.4.3. Japan Biomarkers Market
8.4.4. Australia Biomarkers Market
8.4.5. South Korea Biomarkers Market
8.4.6. Rest of Asia Pacific Biomarkers Market
8.5. Latin America Biomarkers Market Snapshot
8.5.1. Brazil Biomarkers Market
8.5.2. Mexico Biomarkers Market
8.6. Rest of The World Biomarkers Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. F. Hoffmann-la roche ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott laboratories
9.2.3. Epigenomics ag
9.2.4. General electric
9.2.5. Johnson & Johnson services, inc.
9.2.6. Thermo fisher scientific, Inc.
9.2.7. Bio-rad laboratories, inc.
9.2.8. Siemens healthineers ag
9.2.9. Qiagen

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption